4D Pharma Plc ADR (LBPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 05-2020 | 02-2020 | 12-2019 | 11-2019 | 08-2019 | |
| Operating Expenses | 169 | 0 | 39,670 | 290 | 328 |
| Operating Income | -169 | N/A | -39,401 | -290 | -328 |
| Other Income | 45 | 0 | 9,293 | 174 | 209 |
| Pre-tax Income | -124 | 0 | -30,108 | -116 | -119 |
| Net Income Continuous | -124 | N/A | -30,108 | -116 | -119 |
| Net Income | $-124 | $N/A | $-30,108 | $-116 | $-119 |
| EPS Basic Total Ops | -0.08 | N/A | -0.04 | -0.14 | -0.16 |
| EPS Basic Continuous Ops | -0.06 | N/A | -0.34 | -0.06 | -0.07 |
| EPS Diluted Total Ops | -0.08 | N/A | -0.04 | -0.14 | -0.16 |
| EPS Diluted Continuous Ops | -0.06 | N/A | -0.34 | -0.06 | -0.07 |
| EBITDA(a) | $-169 | $N/A | $-39,670 | $-290 | $-328 |